Levamisole HCl: 2.00%w/v
Cobalt Sulphate: 0.40%w/v
Oxyclozanide and Levamisole act against a broad spectrum of gastrointestinal worms and against lung worms. Oxyclozanide is a salicylanilide and acts against Trematodes, bloodsucking nematodes and larvae of hypoderma and Oestrus spp. Levamisole causes an increase of the axial muscle tone followed by paralysis of worms.
Oxyclozanide and Levamisole Oral Suspension is prophylaxis and treatment of gastrointestinal and lung worm infections in cattle, calves, sheep and goats like: Trichostrongylus, Cooperia, Ostertagia, Haemonchus, Nematodirus, Chabertia, Bunostomum, Dictyocaulus and Fasciola (liverfluke) spp.
For treatment & control of round, tape worms, liver fluke & cobalt deficiency.
LIVERFLUKE NO.1 is highly effective at a single dose rate in buffaloes, cattle sheep & goats against:
(1) All stomach and intestinal round worms including nematodirus & ostertagia species.
(2) Lung worms causing hoose & husk.
(3) Tapeworm segments.
(4) Liver flukes.
Pharmacological action: N/A
Usage and administration:
For oral administration.
Cattle, calves : 5 ml. per 10 kg. body weight.
Sheep and goats : 1 ml. per 2 kg. body weight.
Shake well before use.
LIVERFLUKE NO.1 should be used:
1. All times of the year when treatment for both liver fluke and roundworm is necessary.
2. For all brought-in stock.
3. In Summer when simultaneous control of roundworms and removal of liver fluke is required.
Normal worms’ infection without any outward signs can be seriously harmful to production. It is therefore advisable to plan dosing programme on herd or flock basis and not to wait until worm infestation breakout in the entire farm. Such programme should be related to management systems and the major danger periods of worm infection.
Side effect and contraindication: N/A
Wash hands after use of LIVERFLUKE NO.1.
Milking 24 hours and slaughtering 14days.
Storage and expired time:
Protect from heat & light. Store below 30.C.
Melinda Neuhauser provides a broad overview and national perspective on antibiotic use in inpatient settings, unintended consequences of antibiotic use, and antibiotic stewardship programs during the 2017 NHSN Training.
Comments on this video are allowed in accordance with our comment policy:
This video can also be viewed at